SHELBY LEPPIN: Open Payments
NPI 1801381876 · KIRKSVILLE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 30 payments from 6 companies in 2025. Trend: 2023 $289 · 2024 $552 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $201 |
| E.R. Squibb & Sons, L.L.C. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 3 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: VRAYLAR, COBENFY, INGREZZA, SPRAVATO, TRINTELLIX, AUSTEDO XR, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
